Anxiety and Related Sleep Disorders - United States

United States

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach €2.98bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.05%, resulting in a market volume of €3.14bn by 2029.
In global comparison, most revenue will be generated in the United States (€2,980.00m in 2024).
In relation to total population figures, per person revenues of €124.30 are generated in 2024.

Key regions: China, United States, Germany, India, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Anxiety and Related Sleep Disorders market in United States is witnessing significant growth due to changing customer preferences and increasing awareness about mental health issues.

Customer preferences: Customers in the United States are increasingly prioritizing their mental health and seeking solutions for anxiety and related sleep disorders. This is driven by various factors, including the growing recognition of the impact of stress on overall well-being and the availability of information about mental health through various channels, such as social media and online platforms. Additionally, the COVID-19 pandemic has further accelerated the demand for anxiety and sleep disorder treatments, as individuals grapple with increased stress and disrupted sleep patterns.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in United States is the rising popularity of natural and holistic remedies. Many customers are opting for alternative therapies, such as meditation, yoga, and herbal supplements, to manage their anxiety and improve sleep quality. This trend is driven by a desire for more sustainable and drug-free solutions, as well as a growing interest in overall wellness and self-care.Another trend in the market is the increasing adoption of technology-based solutions. Mobile applications and wearable devices that track sleep patterns and provide relaxation techniques are gaining popularity among customers. These digital tools offer convenience and accessibility, allowing individuals to manage their anxiety and sleep disorders from the comfort of their own homes.

Local special circumstances: The United States has a well-developed healthcare system, which includes a wide range of mental health services. This enables individuals to easily access diagnosis and treatment options for anxiety and related sleep disorders. Additionally, the country has a strong pharmaceutical industry, which contributes to the availability of a diverse range of medications for these conditions.

Underlying macroeconomic factors: The growing prevalence of anxiety and related sleep disorders in the United States is influenced by several macroeconomic factors. These include high levels of work-related stress, increasing healthcare costs, and a fast-paced lifestyle. Additionally, the COVID-19 pandemic has had a significant impact on mental health, leading to a surge in anxiety and sleep disorders. The economic downturn caused by the pandemic has also contributed to increased stress and financial insecurity, further exacerbating these conditions.In conclusion, the Anxiety and Related Sleep Disorders market in United States is experiencing growth due to changing customer preferences, including a focus on mental health and a demand for natural remedies. The adoption of technology-based solutions is also on the rise. The well-developed healthcare system and strong pharmaceutical industry in the country contribute to the availability of a wide range of treatment options. The underlying macroeconomic factors, such as work-related stress and the impact of the COVID-19 pandemic, further drive the demand for anxiety and sleep disorder treatments.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.